论文信息 - Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial. - 字舞流文

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

J. Cayuela | A. Baruchel | T. Leblanc | Y. Bertrand | F. Guilhot | P. Bordigoni | F. Millot | C. Galambrun | F. Bernard | C. Edan | F. Mazingue | J. Guilhot | A. Petit | C. Vérité | K. Yacouben | Y. Réguerre | C. Berthoux | Y. Reguerre | G. Couillaud | Lutz Patrick